Microbial imprints on colorectal cancer: the epigenetic silencing of PHLPP1 as a prognostic nexus.
作者信息
Huang Xiangsheng, Bishehsari Faraz
机构信息
Gastroenterology Research Center (GRC), Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
MD Anderson Cancer Center-UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas, USA.
出版信息
BMJ Oncol. 2025 Jul 27;4(1):e000883. doi: 10.1136/bmjonc-2025-000883. eCollection 2025.
Abstract
摘要
相似文献
1
Microbial imprints on colorectal cancer: the epigenetic silencing of PHLPP1 as a prognostic nexus.
BMJ Oncol. 2025 Jul 27;4(1):e000883. doi: 10.1136/bmjonc-2025-000883. eCollection 2025.
2
DNA methylation based biomarkers in colorectal cancer: A systematic review.
Biochim Biophys Acta. 2016 Aug;1866(1):106-20. doi: 10.1016/j.bbcan.2016.07.001. Epub 2016 Jul 3.
3
Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2024 May 15;25(10):5374. doi: 10.3390/ijms25105374.
4
USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.
J Cancer Res Clin Oncol. 2012 Jul;138(7):1231-8. doi: 10.1007/s00432-012-1193-3. Epub 2012 Mar 20.
5
Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.
J Cancer Res Clin Oncol. 2015 Dec;141(12):2097-107. doi: 10.1007/s00432-015-1972-8. Epub 2015 Apr 23.
6
Pseudogenes as Potential Diagnostic, Prognostic and Therapeutic Biomarkers in Colorectal Cancer: A Systematic Review.
Cancer Rep (Hoboken). 2025 Jun;8(6):e70263. doi: 10.1002/cnr2.70263.
7
Microbial biomarkers as a predictor of periodontal treatment response: A systematic review.
J Periodontal Res. 2023 Dec;58(6):1113-1127. doi: 10.1111/jre.13188. Epub 2023 Sep 19.
8
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Surg Oncol. 2018 Jun;27(2):280-288. doi: 10.1016/j.suronc.2018.05.012. Epub 2018 May 8.
9
The prognostic role of epigenetic dysregulation in bladder cancer: A systematic review.
Cancer Treat Rev. 2017 Dec;61:82-93. doi: 10.1016/j.ctrv.2017.10.004. Epub 2017 Nov 6.
10
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.
本文引用的文献
1
Colorectal Cancer: Epidemiology, Risk Factors, and Public Health Strategies.
Digestion. 2025;106(2):91-99. doi: 10.1159/000543921. Epub 2025 Feb 12.
2
Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention.
Epigenomics. 2024 Mar;16(6):403-418. doi: 10.2217/epi-2023-0382. Epub 2024 Feb 27.
3
Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
Front Immunol. 2022 Jan 7;12:807648. doi: 10.3389/fimmu.2021.807648. eCollection 2021.
4
The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development.
Front Oncol. 2021 Apr 15;11:626349. doi: 10.3389/fonc.2021.626349. eCollection 2021.
5
Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24285-24295. doi: 10.1073/pnas.1912129116. Epub 2019 Nov 11.
6
Abnormal Eating Patterns Cause Circadian Disruption and Promote Alcohol-Associated Colon Carcinogenesis.
Cell Mol Gastroenterol Hepatol. 2020;9(2):219-237. doi: 10.1016/j.jcmgh.2019.10.011. Epub 2019 Nov 2.
7
Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention.
BMJ Open Gastroenterol. 2017 Jul 3;4(1):e000145. doi: 10.1136/bmjgast-2017-000145. eCollection 2017.
8
Epigenetics and colorectal cancer.
Nat Rev Gastroenterol Hepatol. 2011 Oct 18;8(12):686-700. doi: 10.1038/nrgastro.2011.173.
Zotero 插件